XNK Therapeutics

0 followers


XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.

Industries

Headquarters

Huddinge, Sweden

Employees

11-50

Links

Org chart

Hans Ericson
Chief Financial Officer
Stephan Meinke
Head of R&D
Michael Uhlin
Chief Scientific Officer
Julia Remnestål
Regulatory Affairs Manager
Paul Do
Head of Clinical Manufacturing and Engineering
Zahra Rajabkhani
Production Lead
Karin Mellström
Senior Project Manager